About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Opiate-Induced Tolerance & Hyperalgesia in Pain Patients

NCT00246532·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

National Institute of General Medical Sciences (NIGMS)

Age

18–70

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

opioid naïve (or less than 4 vicodin equiv/day)
18-70 years old
candidate for opioid therapy for nonmalignant pain.

You may not be if

history of substance abuse or severe psychiatric disease
use of medications for the treatment of neuropathic pain as these may alter tolerance or hyperalgesia
neurological conditions interfering with experimental pain testing, e.g. severe peripheral neuropathy

The record

StatusCompleted

PhasePhase 4

Taking part139

StartedOct 2005

UpdatedApr 30, 2012

Conditions

Chronic Low Back Pain Opioid-induced Hyperalgesia

Where1

Stanford University School of Medicine
Stanford, California, United States

Clareo Health | Opiate-Induced Tolerance & Hyperalgesia in Pain Patients